Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 449, 29-30 (6 September 2007) | doi:10.1038/449029a; Published online 5 September 2007
Open Innovation Challenges
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
- More Challenges
- Powered by:
nature jobs
Project Manager – Scientist in Emulsions and Foams
- Nestle Research Center
- Lausanne, Switzerland
Research Scientist – Ecology of Phytoplankton and Primary Producers (Experimental Lakes Area)
- Fisheries and Oceans Canada (DFO)
- Winnipeg, Manitoba, Canada
HIV/AIDS: Allied responses
John R. Mascola1
Abstract
The main function of neutralizing antibodies is to block viral entry into host cells. But, for maximal protection against HIV, such antibodies must call upon other elements of the immune system to help with the job.
More than two decades into the AIDS pandemic, and despite intense research on the human immunodeficiency virus (HIV), we still do not have a vaccine to prevent HIV infection. One possibility is to trigger the components of adaptive (specific) immunity1 — T cells and B-cell-derived antibodies.
- John R. Mascola is at the Vaccine Research Center, NIAID, NIH, 40 Convent Drive, MSC 3015, Bethesda, Maryland 20892, USA.
Email: jmascola@nih.gov
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
IgG surfaces as an important component in mucosal protectionNature Medicine News and Views (01 Feb 2000)
Is an HIV vaccine possible?Nature Medicine News and Views (01 Jun 1999)
See all 9 matches for News And ViewsRESEARCH
Fc receptor but not complement binding is important in antibody protection against HIVNature Letters to Editor (06 Sep 2007)
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian?human immunodeficiency virus infectionNature Medicine Article (01 Feb 2000)
See all 12 matches for Research